Third Annual Diabetes Drug Discovery
World Trade Center
200 Seaport Blvd.
Boston, 02210, Massachusetts

Schedule of Presentations:

Wednesday, November 3, 2010
12:30:00 Conference Registration
13:25:00 Diabetes Drug Development Challenges
13:30:00 Chairperson’s Remarks Rebecca Taub
13:40:00 KEYNOTE PRESENTATION : Future Treatment of Diabetes: Integrating Perspectives From Bench, Bedside, and Beyond Jorge Plutzky
15:10:00 Networking Refreshment Break in the Exhibit Hall
15:40:00 Targeting G Protein Coupled Receptors to Modulate Insulin Levels
15:45:00 Glucagon Receptor Antagonists (tentative title) Michelle Miller
16:15:00 Sponsored Presentation (Opportunity Available)
16:45:00 GPR39, A Novel Target for Type-2 Diabetes and Obesity Birgitte Holst
17:15:00 Targeting Entero-endocrine 7TM Chemo-sensors for Metabolic Diseases Thue W Schwartz.
17:45:00 End of Day
Thursday, November 4, 2010
07:30:00 Interactive Breakfast Breakout Discussion Groups
07:35:00 Topic: How Will We Discover Novel Therapies for Diabetes that are Safe and Efficacious? Andrew G. Swick
07:40:00 Topic: Challenges in Pancreatic Regeneration-Approaches Rohit Kulkarni
07:45:00 Topic: Preclinical Development of Diabetes Compounds – Pitfalls to Avoid
08:30:00 New Diabetes Pathways and Drug Candidates
08:35:00 Chairperson’s Opening Remarks Andrew G. Swick
08:40:00 11beta-HSD1 Inhibition in Type 2 Diabetes Reid Huber
09:10:00 Separating Mitogenic and Metabolic Activities of FGF19 Yang Li
09:40:00 Use of a Small Molecule Inhibitor of Macrophage Migration Inhibitory Factor is Therapeutic in Treatment of Non-Insulin-Dependent Diabetes Mellitus Thais Sielecki
10:10:00 Networking Coffee Break in the Exhibit Hall
10:55:00 Systems Approaches to Modeling Diabetes within Pfizer With Applications to SGLT2i Avijit Ghosh
11:25:00 Update on a New Diabetes Target (tentative title) Andrée R. Olivier
11:55:00 GPR119 Agonists for the Treatment of Diabetes Graeme Semple
12:25:00 Sponsored Presentation (Opportunity Available)
12:40:00 Luncheon Presentation (Sponsorship Opportunity Available) or Lunch on Your Own
13:50:00 Targeting the Pancreas and Obesity
13:55:00 Chairperson’s Remarks Michael Trautmann Michael Trautmann
14:00:00 Regenerating Pancreatic Islet Cells Rohit Kulkarni
14:30:00 Preclinical Developmet of Peptide Therapeutic that Stimulates Pancreas Regeneration H. Joseph Reiser
14:55:00 Targeting the Pancreas and Obesity (cont'd)
15:00:00 Networking Ice Cream Refreshment Break in the Exhibit Hall
15:40:00 Contrave: Weight Loss and Improvements in A1C in Patients with Type 2 Diabetes Dennis Kim
16:10:00 Enteropeptidase: A Gene Associated to a Lean Human Phenotype as a Novel Target for the Treatment Obesity and Type II Diabetes Itzik Harosh
16:40:00 Preclinical Models for Quantifying Pancreatic Beta Cell Regulation Alokesh Duttaroy
3D Tissue Models
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.